Validation

Microbiome-targeted intervention validation reports.

26 Validation

Hyperbaric Oxygen Therapy (HBOT) as a Promising Candidate in Endometriosis treatment

Lactulose: A Validated Microbiome-Targeted Intervention for CKD Management

Probiotics as microbiome-targeted intervention for Vulvovaginal Candidiasis (VVC)

Validation of a Low-Nickel Diet as an microbiome-targeted intervention for Endometriosis

Validation of Boric Acid (BA) as a microbiome-targeted intervention for Bacterial Vaginosis and Vulvovaginal Candidiasis (VVC)

Validation of Bovine Lactoferrin as a Microbiome-Targeted Intervention for Bacterial Vaginosis

Validation of Cannabidiol (CBD) as a microbiome-targeted intervention for Bacterial Vaginosis

Validation of Clindamycin as a microbiome-targeted intervention for Bacterial Vaginosis

Validation of curcumin and fecal microbiota transplantation as microbiome-targeted intervention for Polycystic ovary syndrome (PCOS)

Validation of Essential Oils as a Microbiome-Targeted Intervention for Biofilms

Validation of Glatiramer Acetate as a Microbiome-Targeted Intervention for Multiple Sclerosis

Validation of Maltose Gel (Prebiotic) as a Microbiome-Targeted Intervention for Bacterial Vaginosis

Validation of Metformin as a Microbiome-targeted intervention for Endometriosis

Validation of Metformin as a Microbiome-Targeted Intervention for Polycystic ovary syndrome (PCOS)

Validation of Metronidazole as a microbiome-targeted intervention for Bacterial Vaginosis

Validation of Metronidazole as a microbiome-targeted intervention for Endometriosis

Validation of Probiotic Therapy as a Microbiome-Targeted Intervention for Bacterial Vaginosis

Validation of Probiotics as a Microbiome-targeted intervention for Pelvic Inflammatory Disease

Validation of Probiotics as a Microbiome-Targeted Intervention for Polycystic ovary syndrome (PCOS)

Validation of Pueraria Flower Extract (PFE) as a Microbiome-targeted intervention for Endometriosis

Validation of Resistant Dextrin as a Microbiome-Targeted Intervention for Polycystic ovary syndrome (PCOS)

Validation of Secnidazole as a Microbiome-Based Therapeutic Intervention for Bacterial Vaginosis

Validation of Statin Therapy as a Microbiome-Targeted Intervention for Polycystic ovary syndrome (PCOS)

Validation of Synbiotics as a Microbiome-Targeted Intervention for Polycystic ovary syndrome (PCOS)

Validation of Tinidazole as a microbiome-targeted intervention for Bacterial Vaginosis

Validation of Vitamin C as a Microbiome-Based Therapy for Recurrent Bacterial Vaginosis